TAK-875 (Fasiglifam) - GPR40 Agonist. CAS# 1374598-80-7 0083 (+)-JQ1 potently decreases expression of

(+)-JQ1 potently decreases expression of both BRD4 target genes

InChi: InChI=1S/C17H15ClO2/c18-16-10-7-13(8-11-16)6-9-15(12-17(19)20)14-4-2-1-3-5-14/h1-5

AA92593 was dosed intraperitoneally 30 mg/kg 20 min before PLR measurement attenuated pupil constriction in response to light (1013 ph cm-2 s-1) by ~50% in adult rd mice

a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120)

TAK-875 (Fasiglifam) - GPR40 Agonist. CAS# 1374598-80-7 0083 (+)-JQ1 potently decreases expression ofTAK 875 (Fasiglifam), CAS No. 1374598 80 7, is the potent, selective and orally bioavailable partial GPR40 agonist with an EC50 ~14 nM. It has binding affinity to the human GPR40 receptor with Ki of 38 nM and the rat GPR40 receptor with Ki of 140 nM. TAK 875 has no agonist potency to other members of the FFA receptor family with EC50 >10 M. The 2. 3 resolution co complex structure of hGPR40 TAK 875 reveals a unique binding mode of TAK 875 and suggests